XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.33

-1.9%

Dec 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (15881)	7/16/2002 12:59:21 AM
From: aknahow	Read Replies (1) of 17367

Getting a complete response letter is a serious event. You were one of those who thought that the FDA gave BGEN a complete response to their BLA. Only after some time did you admit that it was BGEN that was obligated to provide a response to the FDA that was complete in every way. I did not know until Flu Mist that there was a possibility that another request for a complete response could be made after the first one was replied to. The Amevive saga is not yet over, and of course the Xanelim saga has just begun. I do not know when the FDA will receive the complete response from BGEN, nor do I know when they will respond to BGEN, nor do I know that they will not simply ask for another complete response.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next